CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases
Open Access
- 24 January 2007
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 21 (2) , 356-359
- https://doi.org/10.1038/sj.leu.2404499
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- NK cell subsets and CD107a mobilization assayLeukemia, 2005
- CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targetsLeukemia, 2005
- Ex vivo identification, isolation and analysis of tumor-cytolytic T cellsNature Medicine, 2003
- The biology of human natural killer-cell subsetsTrends in Immunology, 2001
- Downregulation of Fcγ Receptor IIIAα (CD16-II) on Natural Killer Cells Induced by Anti-CD16 mAb Is Independent of Protein Tyrosine Kinases and Protein Kinase CCellular Immunology, 1994
- A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.The Journal of Immunology, 1994
- Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II).The Journal of Immunology, 1991
- Comparative studies of human FcRIII-positive and negative natural killer cells.The Journal of Immunology, 1989